Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC (2015)
Publication Type: Journal article
Publication year: 2015
Journal
Book Volume: 88
Pages Range: 17-27
Journal Issue: 1
DOI: 10.1038/ki.2015.59
Abstract
Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals and is the fourth most common cause for renal replacement therapy worldwide. There have been many recent advances in the understanding of its molecular genetics and biology, and in the diagnosis and management of its manifestations. Yet, diagnosis, evaluation, prevention, and treatment vary widely and there are no broadly accepted practice guidelines. Barriers to translation of basic science breakthroughs to clinical care exist, with considerable heterogeneity across countries. The Kidney Disease: Improving Global Outcomes Controversies Conference on ADPKD brought together a panel of multidisciplinary clinical expertise and engaged patients to identify areas of consensus, gaps in knowledge, and research and health-care priorities related to diagnosis; monitoring of kidney disease progression; management of hypertension, renal function decline and complications; end-stage renal disease; extrarenal complications; and practical integrated patient support. These are summarized in this review.
Authors with CRIS profile
Involved external institutions
Tufts University
United States (USA) (US)
Université Catholique de Louvain (UCL)
Belgium (BE)
University of Colorado System
United States (USA) (US)
Autonomous University of Barcelona (UAB) / Universitat Autònoma de Barcelona
Spain (ES)
Mayo Clinic
United States (USA) (US)
University of Maryland
United States (USA) (US)
University College London (UCL)
United Kingdom (GB)
Emory University
United States (USA) (US)
University of Zurich / Universität Zürich (UZH)
Switzerland (CH)
University of Groningen / Rijksuniversiteit Groningen
Netherlands (NL)
PKD International
Switzerland (CH)
Juntendo University
Japan (JP)
Hennepin County Medical Center
United States (USA) (US)
PKD Foundation
United States (USA) (US)
University of Toronto
Canada (CA)
United States (USA) (US)
Université Catholique de Louvain (UCL)
Belgium (BE)
University of Colorado System
United States (USA) (US)
Autonomous University of Barcelona (UAB) / Universitat Autònoma de Barcelona
Spain (ES)
Mayo Clinic
United States (USA) (US)
University of Maryland
United States (USA) (US)
University College London (UCL)
United Kingdom (GB)
Emory University
United States (USA) (US)
University of Zurich / Universität Zürich (UZH)
Switzerland (CH)
University of Groningen / Rijksuniversiteit Groningen
Netherlands (NL)
PKD International
Switzerland (CH)
Juntendo University
Japan (JP)
Hennepin County Medical Center
United States (USA) (US)
PKD Foundation
United States (USA) (US)
University of Toronto
Canada (CA)
How to cite
APA:
Chapman, A.B., Devuyst, O., Eckardt, K.-U., Gansevoort, R.T., Harris, T., Horie, S.,... Wheeler, D.C. (2015). Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 88(1), 17-27. https://doi.org/10.1038/ki.2015.59
MLA:
Chapman, Arlene B., et al. "Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference." Kidney International 88.1 (2015): 17-27.
BibTeX: Download